Serious adverse events (52 weeks) · Patients with quiescent ulcerative colitis
It is very uncertain whether probiotics changes serious adverse events (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · induction of remission in Crohn's disease
It is very uncertain whether probiotics changes adverse events leading to withdrawal compared with placebo (very low certainty).
1 finding from 1 review
Serious adverse events (48 to 52 weeks) · Patients with quiescent ulcerative colitis
1 finding from 1 review
Withdrawals due to adverse events · Patients with quiescent ulcerative colitis
It is very uncertain whether probiotics changes withdrawal due to adverse events (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
1 finding from 1 review
Adverse events (serious adverse reaction and adverse reaction) · children and adults with CF
Probiotics showed no clear difference in adverse events (serious adverse reaction and adverse reaction) compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · patients with acute pancreatitis
It is very uncertain whether probiotics changes serious adverse events compared with control (very low certainty).
1 finding from 1 review
Number of women with adverse events · postpartum breastfeeding women
Probiotics may leads to lower number of women with adverse events compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events · children with chronic constipation without a physical explanation
1 finding from 1 review
Withdrawals due to adverse events · children with chronic constipation without a physical explanation
It is very uncertain whether probiotics and osmotic laxative changes withdrawal due to adverse events compared with osmotic laxative (very low certainty).
1 finding from 1 review
Minor adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · people with active UC
It is very uncertain whether antibiotics plus probiotics changes serious adverse events compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Rate of serious adverse events · non‐pregnant women with vulvovaginal candidiasis
Probiotics used as adjuvants to conventional antifungal drugs showed no clear difference in rate of serious adverse events compared with conventional antifungal drugs (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · people with active UC
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · adults with vestibular migraine
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with active UC
It is very uncertain whether antibiotics plus probiotics changes withdrawals due to adverse events compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events ‐ not reported · patients with acute pancreatitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adult patients after liver transplantation.
It is very uncertain whether synbiotics changes adverse events compared with prebiotics (very low certainty).
1 finding from 1 review
Adverse events · adult kidney transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · Children receiving antibiotic treatment between 4 and 28 days duration for a variety of infections
The intervention showed no clear difference in adverse events (low certainty).
1 finding from 1 review